Literature DB >> 21249091

Current medical management of peptic ulcer disease.

B E Lukie.   

Abstract

Peptic ulceration occurs when the digestive action of gastric secretions overcomes gastroduodenal mucosal defences. The therapeutic strategy used to correct this imbalance uses drugs that either reduce gastric secretion or increase mucosal resistance. Traditional therapies of dietary manipulation and antacid administration no longer play major roles in peptic ulcer therapy. Uncomplicated peptic ulcers respond quite well to drug treatment, although recurrences are common and may require long-term maintenance therapy. Drug-induced gastric ulcers have represented a challenging problem, for which effective therapy is now available.

Entities:  

Year:  1989        PMID: 21249091      PMCID: PMC2280934     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  8 in total

Review 1.  Antacids in the treatment of gastroduodenal ulcer.

Authors:  A Berstad; R Weberg
Journal:  Scand J Gastroenterol       Date:  1986-05       Impact factor: 2.423

2.  Response to placebos in ulcer disease.

Authors:  B Gudjonsson; H M Spiro
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

3.  Costs of medical and surgical treatment of duodenal ulcer.

Authors:  A Sonnenberg
Journal:  Gastroenterology       Date:  1989-06       Impact factor: 22.682

Review 4.  Ulcer complications during short-term therapy of duodenal ulcer with active agents and placebo.

Authors:  L R Schiller; J S Fordtran
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

5.  Gastric ulcer recurrence: follow-up of a double-blind, placebo-controlled trial.

Authors:  J D Wolosin; S L Gertler; W L Peterson; M A Sandersfeld; J I Isenberg
Journal:  J Clin Gastroenterol       Date:  1989-02       Impact factor: 3.062

Review 6.  Silent peptic ulceration: deadly silence or golden silence?

Authors:  R Pounder
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

Review 7.  Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

8.  Recurrent ulcer after successful treatment with cimetidine or antacid.

Authors:  A Ippoliti; J Elashoff; J Valenzuela; R Cano; H Frankl; M Samloff; R Koretz
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.